In COVID-19 patients, a polyclonal anti-RBM436-507 antibody response with IgM, IgG and IgA isotypes was detected in one third of the cases, in amounts correlated with the level of anti-RBD and anti-S antibodies. This evidence concerns the gene CD40LG and COVID-19.